Can a nightly eye drop stop kids' eyesight from getting worse?

NCT ID NCT07456488

Recruiting now Disease control Sponsor: Liaquat National Hospital & Medical College Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a very low dose of atropine eye drops (0.01%) given once nightly can slow the progression of nearsightedness (myopia) in children aged 4 to 16. Over 6 months, 60 children will either receive the drops or be in a control group. The goal is to see if the drops reduce the lengthening of the eye and slow the need for stronger glasses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: atropine 0.01% eye drops
What this could lead to: If it works, this could offer a simple way to slow down worsening nearsightedness in children, reducing the need for stronger glasses later.
What could go wrong: This is a small, early-phase study with only 60 children. The effect may be modest, and long-term safety or benefits are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCUS ON AXIAL LENGTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOCUS ON AXIAL LENGTH

Contacts and locations

Locations

LiaquatNHMC
RECRUITING

Karachi, Sindh, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.